XIENCE PRIME EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Report
- Report Number
- 2024168-2020-02349
- Event Type
- Injury
- Date Received
- March 12, 2020
- Date of Event
- November 15, 2019
- Report Date
- September 17, 2020
- Manufacturer
- ABBOTT VASCULAR
- Product Code
- NIQ
- PMA / PMN Number
- P110019
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- IN
- Reporter Occupation
- PHYSICIAN
Narratives
NAG4 - THE LOT NUMBER WAS CHANGED FROM 9071641 TO 7081641 G4 - THE EXPIRATION DATE WAS CHANGED FROM 7/22/2022 TO 8/21/2020. H4 - THE MANUFACTURING DATE WAS CHANGED FROM 7/23/2019 TO 8/22/2017.
THE DEVICE WAS NOT RETURNED FOR EVALUATION. A REVIEW OF THE LOT HISTORY RECORD IDENTIFIED NO MANUFACTURING NONCONFORMITIES ISSUED TO THE REPORTED LOT THAT WOULD HAVE CONTRIBUTED TO THIS EVENT. THE REPORTED PATIENT EFFECT OF DISSECTION IS LISTED IN THE XIENCE PRIME, XIENCE PRIME SMALL VESSEL (SV), AND XIENCE PRIME LONG LENGTH (LL), EVEROLIMUS ELUTING CORONARY STENT SYSTEMS INSTRUCTIONS FOR USE AS A KNOWN PATIENT EFFECT OF CORONARY STENTING PROCEDURES. A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECT, AND THE RELATIONSHIP TO THE PRODUCT, IF ANY, CANNOT BE DETERMINED. THERE IS NO INDICATION OF A PRODUCT QUALITY ISSUE WITH RESPECT TO MANUFACTURE, DESIGN OR LABELING.
IT WAS REPORTED THAT THE PROCEDURE WAS PERFORMED TO TREAT A HEAVILY CALCIFIED, HEAVILY TORTUOUS DE NOVO RIGHT CORONARY ARTERY THAT WAS 99% STENOSED. PRE-DILATATION WAS DONE WITH AN UNSPECIFIED BALLOON. A 3.0X23MM XIENCE PRIME STENT WAS DEPLOYED AND A DISTAL EDGE DISSECTION OCCURRED. A NEW XIENCE PRIME STENT WAS DEPLOYED TO COVER THE DISSECTION AND SUCCESSFULLY COMPLETE THE PROCEDURE. THERE WAS NO ADVERSE PATIENT SEQUELA REPORTED. NO ADDITIONAL INFORMATION WAS PROVIDED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 288036 | XIENCE PRIME EVEROLIMUS ELUTING CORONARY STENT SYSTEM | DRUG ELUTING CORONARY STENT DELIVERY SYSTEM | NIQ | ABBOTT VASCULAR | 7081641 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Required Intervention |